Beranda › Infeksi COVID-19 dan Coronavirus › California
Uji klinis Infeksi COVID-19 dan Coronavirus di California
12 studi untuk Infeksi COVID-19 dan Coronavirus mencari peserta di lokasi di California.
Kota di California
Teks studi resmi (Bahasa Inggris)
Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Fresno
- Research Site, Newport Beach
- Research Site, Torrance
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05624450A Study to Learn About the Study Medicine Ibuzatrelvir in Adults With COVID-19 Who Are Severely Immunocompromised
- Hope Clinical Research, Inc., Canoga Park
- Amicis Research Center - Granada Hills, Granada Hills
- Jacobs Medical Center at UC San Diego Health, La Jolla
- dan 4 lainnya
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07013474Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
- University of California, Los Angeles (UCLA), Los Angeles
- University of California San Francisco, San Francisco
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06631287A Study to Learn About a Study Medicine Called Ibuzatrelvir in Adult and Adolescent Patients With COVID-19 Who Are Not Hospitalized But Are at Risk For Severe Disease
- National Institute of Clinical Research - Bakersfield, Bakersfield
- Velocity Clinical Research, Huntington Park, Huntington Park
- 310 Clinical Research, Inglewood
- dan 9 lainnya
Menerima pesertaFase 3
Usia 12 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06679140Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- Lucile Packard Children's Hospital, Palo Alto
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 0 hingga 20 · Semua jenis kelamin · Diperbarui 21 Agu 2026 · NCT04278404A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses
- UCLA Westwood, Los Angeles
- UCSF Community and Clinical Research Center, San Francisco
Menerima pesertaFase 1/2Sukarelawan sehat diterima
Usia 40 hingga 64 · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT06810934A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years of Age
- Diablo Clinical Research, LLC dba Flourish Research, Walnut Creek
Menerima pesertaFase 4Sukarelawan sehat diterima
Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 7 Agu 2026 · NCT07730450Long-term Impact of Infection With Novel Coronavirus (COVID-19)
- Zuckerberg San Francisco General Hospital (ZSFG), San Francisco
Menerima pesertaStudi observasional
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 23 Jul 2026 · NCT04362150Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
- City of Hope cancer Center, Duarte
- University of California Davis Health System, Sacramento
Menerima pesertaFase 3
Semua usia · Semua jenis kelamin · Diperbarui 23 Jun 2026 · NCT03808922Impact of the Coronavirus (COVID-19) on Patients With Cancer
- Stanford University School of Medicine, Stanford
Menerima pesertaStudi observasional
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 27 Apr 2026 · NCT04330521Understanding Immunity to the Flu Vaccine in COVID-19 Patients
- Stanford University, Palo Alto
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 9 hingga 64 · Semua jenis kelamin · Diperbarui 18 Mar 2026 · NCT04579588Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
- Department of Emergency Medicine, Children's Hospital of Los Angeles, Los Angeles
Menerima pesertaSukarelawan sehat diterima
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 5 Sep 2025 · NCT05868239Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.